Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.
A new report offers recommendations for extending telehealth treatment of opioid use disorder.
Regulations on decontaminating former meth labs vary across federal and state governments.
To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.
Amid the coronavirus, the federal government eases restrictions on prescribing controlled substances by telehealth.
To fight opioid misuse, the U.S. government proposes expanding access to medical records on substance use.
This Saturday Seminar explores how regulation addresses and affects opioid use and addiction.
As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.